Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods
Open Access
- 1 August 2005
- journal article
- research article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 14 (4) , 369-395
Abstract
Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of examples and then introduce instrumental variable methods for the analysis of such trials. We concentrate mainly on situations in which compliance is all or nothing (either the patient receives the allocated treatment or they do not - in the latter case they may receive no treatment or a treatment other than the one allocated). The main purpose of the review is to illustrate the use of latent class (finite mixture) models, using maximum likelihood, for complier-average causal effect estimation under varying assumptions concerning the mechanism of the missing outcome data.Keywords
This publication has 47 references indexed in Scilit:
- Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-upThe British Journal of Psychiatry, 2003
- Model misspecification sensitivity analysis in estimating causal effects of interventions with non‐complianceStatistics in Medicine, 2002
- Estimating a treatment effect in survival studies in which patients switch treatmentStatistics in Medicine, 2002
- Analyzing a Randomized Cancer Prevention Trial with a Missing Binary Outcome, an Auxiliary Variable, and All-or-None ComplianceJournal of the American Statistical Association, 2000
- Two-Stage Least Squares Estimation of Average Causal Effects in Models with Variable Treatment IntensityJournal of the American Statistical Association, 1995
- Correcting for non-compliance in randomized trials using structural nested mean modelsCommunications in Statistics - Theory and Methods, 1994
- Compliance as an Explanatory Variable in Clinical TrialsJournal of the American Statistical Association, 1991
- Randomized consent designs for clinical trials: An updateStatistics in Medicine, 1990
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effectMathematical Modelling, 1986
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979